Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Hedge Funds > Samsara BioCapital > News, Interviews, and Investor Letters

Hedge Fund - Samsara BioCapital

News, Interviews, and Investor Letters
  • Displaying 2
Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital

Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital

In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.

Keep Reading →

February 17th, 2022 - Hedge Funds News

15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital

15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital

In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.

Keep Reading →

September 29th, 2021 - Hedge Funds News

Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)